The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential
Open accessAbstract
Several tetracycline-controlled transactivators (tTA) were generated which differ in their activation potential by >3 orders of magnitude. The transactivators are fusions between the Tet repressor and minimal transcriptional activation domains derived from Herpes simplex virus protein 16 (VP16). By reducing the VP16 moiety of the previously described tTA to 12 amino acids, potential targets for interactions with various cellular transcription factors were eliminated, as were potential epitopes which may elicit a cellular immune response. When compared with the originally described tTA, these new transactivators are tolerated at higher intracellular concentrations. This will facilitate establishment of tet regulatory systems under a variety of conditions, but particularly when cell type-restricted tetracycline-controlled gene expression is to be achieved in transgenic organisms via homologous recombination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Experiments in molecular genetics
Miller, J. H. (1972) · Medical Entomology and Zoology · Cited by 27,157
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Transcriptional Activation by Tetracyclines in Mammalian Cells
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H. (1995) · Science · doi:10.1126/science.7792603 · Cited by 2,488
Self-citationComparison of initiation of protein synthesis in procaryotes, eucaryotes, and organelles
Kozak, M. (1983) · Microbiological Reviews · doi:10.1128/mmbr.47.1.1-45.1983 · Cited by 1,502
A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus
BOSHART, M., WEBER, F., JAHN, G., DORSCHHLER, K., FLECKENSTEIN, B., & SCHAFFNER, W. (1985) · Cell · doi:10.1016/s0092-8674(85)80025-8 · Cited by 1,140
Resnitzky, D., Gossen, M., Bujard, H., & Reed, S. I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1669-1679.1994 · Cited by 965
Triezenberg, S. J., Kingsbury, R. C., & McKnight, S. L. (1988) · Genes & Development · doi:10.1101/gad.2.6.718 · Cited by 811
Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.
Kistner, A., Gossen, M., Zimmermann, F., Jerecic, J., Ullmer, C., Lübbert, H., & Bujard, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10933 · Cited by 778
Negative effect of the transcriptional activator GAL4
Gill, G., & Ptashne, M. (1988) · Nature · doi:10.1038/334721a0 · Cited by 665
Cited by
Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells
Masui, S., Nakatake, Y., Toyooka, Y., Shimosato, D., Yagi, R., Takahashi, K., Okochi, H., Okuda, A., Matoba, R., Sharov, A. A., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1589 · Cited by 1,252
The TetR Family of Transcriptional Repressors
Ramos, J. L., Martínez-Bueno, M., Molina-Henares, A. J., Terán, W., Watanabe, K., Zhang, X., Gallegos, M. T., Brennan, R., & Tobes, R. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.2.326-356.2005 · Cited by 1,103
Synthetic biology: new engineering rules for an emerging discipline
Andrianantoandro, E., Basu, S., Karig, D. K., & Weiss, R. (2006) · Molecular Systems Biology · doi:10.1038/msb4100073 · Cited by 1,081
Urlinger, S., Baron, U., Thellmann, M., Hasan, M. T., Bujard, H., & Hillen, W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130192197 · Cited by 928
Self-citationConditional control of gene expression in the mouse
Lewandoski, M. (2001) · Nature Reviews Genetics · doi:10.1038/35093537 · Cited by 781
Chromosomal silencing and localization are mediated by different domains of Xist RNA
Wutz, A., Rasmussen, T. P., & Jaenisch, R. (2002) · Nature Genetics · doi:10.1038/ng820 · Cited by 737
Asakawa, K., Suster, M. L., Mizusawa, K., Nagayoshi, S., Kotani, T., Urasaki, A., Kishimoto, Y., Hibi, M., & Kawakami, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704963105 · Cited by 560
Neuhold, L. A., Killar, L., Zhao, W., Sung, M.-L. A., Warner, L., Kulik, J., Turner, J., Wu, W., Billinghurst, C., Meijers, T., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10564 · Cited by 540
Tet-On Systems For Doxycycline-inducible Gene Expression
T. Das, A., Tenenbaum, L., & Berkhout, B. (2016) · Current Gene Therapy · doi:10.2174/1566523216666160524144041 · Cited by 434
“This AD minimization removed potential targets for interactions with cellular transcription factors, which reduced toxic squelching effects [16].”
BackgroundOccurrence of leukaemia following gene therapy of X-linked SCID
Kohn, D. B., Sadelain, M., & Glorioso, J. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1122 · Cited by 344
Baron, U., & Bujard, H. (2000) · Methods in Enzymology · doi:10.1016/s0076-6879(00)27292-3 · Cited by 335
Self-citationThe somatic mutation theory of cancer: growing problems with the paradigm?
Soto, A. M., & Sonnenschein, C. (2004) · BioEssays · doi:10.1002/bies.20087 · Cited by 295
Optimized Gal4 genetics for permanent gene expression mapping in zebrafish
Distel, M., Wullimann, M. F., & Köster, R. W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903060106 · Cited by 289
Hudson, D. F., Vagnarelli, P., Gassmann, R., & Earnshaw, W. C. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00199-0 · Cited by 281
Berens, C., & Hillen, W. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03694.x · Cited by 261
Freundlieb, S., Schirra‐Müller, C., & Bujard, H. (1999) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(199901/02)1:1<4::aid-jgm4>3.0.co;2-y · Cited by 261
Improved Tet-responsive promoters with minimized background expression
Loew, R., Heinz, N., Hampf, M., Bujard, H., & Gossen, M. (2010) · BMC Biotechnology · doi:10.1186/1472-6750-10-81 · Cited by 246
Self-citationOptimization of the Tet-On system for regulated gene expression through viral evolution
Zhou, X., Vink, M., Klaver, B., Berkhout, B., & Das, A. T. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302780 · Cited by 224
Silencing and un-silencing of tetracycline-controlled genes in neurons
Zhu, P., Aller, M. I., Baron, U., Cambridge, S., Bausen, M., Herb, J., Sawinski, J., Cetin, A., Osten, P., Nelson, M. L., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000533 · Cited by 136
Self-citationViral Evolution as a Tool to Improve the Tetracycline-regulated Gene Expression System
Das, A. T., Zhou, X., Vink, M., Klaver, B., Verhoef, K., Marzio, G., & Berkhout, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313895200 · Cited by 129
Latta-Mahieu, M., Rolland, M., Caillet, C., Wang, M., Kennel, P., Mahfouz, I., Loquet, I., Dedieu, J.-F., Mahfoudi, A., Trannoy, E., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340260201707 · Cited by 114
Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina
McGee Sanftner, L. H., Rendahl, K. G., Quiroz, D., Coyne, M., Ladner, M., Manning, W. C., & Flannery, J. G. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0308 · Cited by 94
Strict Control of Human Immunodeficiency Virus Type 1 Replication by a Genetic Switch: Tet for Tat
Verhoef, K., Marzio, G., Hillen, W., Bujard, H., & Berkhout, B. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.979-987.2001 · Cited by 88
“The Tet system is ideally suited to modulate the level of transcriptional activation in a stepwise manner by changing the amount of dox (4).”
BackgroundSelf-citationMarkusic, D. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni062 · Cited by 78
“Mutagenesis and codon optimization of the TetR and reduction of the VP16 activation domain to three repeats of a 12 amino acid minimal activation domain (10) generated an improved rtTA, rtTA2-S2 (11), with reduced background activity.”
MethodA Single Lentivirus Vector Mediates Doxycycline-Regulated Expression of Transgenes in the Brain
Vogel, R., Amar, L., Thi, A. D., Saillour, P., & Mallet, J. (2004) · Human Gene Therapy · doi:10.1089/104303404772679968 · Cited by 68
Ginhoux, F., Turbant, S., Gross, D. A., Poupiot, J., Marais, T., Lone, Y., Lemonnier, F. A., Firat, H., Perez, N., Danos, O., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.05.012 · Cited by 49
Das, A. T., Zhou, X., Metz, S. W., Vink, M. A., & Berkhout, B. (2016) · Biotechnology Journal · doi:10.1002/biot.201500236 · Cited by 36
“Different strategies have been used to improve the Tet-On system, including the introduction of rationally designed mutations and minimalization of the VP16 activation domain [9], human codon usage optimization and removal of putative splice sites [10], and random mutagenesis followed by functional screening in yeast…”
MethodBarton, M. D., Dunlop, J. W., Psaltis, G., Kulik, J., DeGennaro, L., & Kwak, S. P. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00170-5 · Cited by 23
Metadata
- Authors
- Baron, U.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-07-15
- Volume
- 25
- Issue
- 14
- Pages
- 2723-2729
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2058527659
- Cited by
- 335
- References
- 25
- FWCI
- 7.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.